Dec 9 (Reuters) - Eli Lilly said on Tuesday it will invest more than $6 billion in a new active drug ingredient manufacturing facility in Huntsville, Alabama, to expand U.S. production and bolster medicine supply chains.
The site, the third new U.S. facility announced by Lilly, will make small-molecule synthetic and peptide medicines, including orforglipron, its first oral GLP-1 weight-loss drug anticipated to receive U.S. approval early next year.
Global pharmaceutical companies have been increasing U.S. investments after President Donald Trump urged the industry to make more medicines domestically rather than importing active ingredients or finished medicines.
Earlier this year, Lilly outlined plans to spend at least $27 billion on four new U.S. manufacturing sites to counter potential drug import duties. Lilly said another location will be announced in the coming weeks.
The company said the construction is slated to begin in 2026, creating about 3,000 construction jobs, with completion targeted for 2032. Lilly also plans 450 roles for engineers, scientists, operations personnel and lab technicians in the area.
CEO David Ricks said the investment advances the onshoring of active pharmaceutical ingredient production to strengthen supply resilience.
The company estimates every dollar invested could generate up to four dollars in local economic activity.
The site was chosen from more than 300 applications, aided by proximity to the HudsonAlpha Institute for Biotechnology, an established bioscience campus supporting workforce training and research, Lilly said.
Alabama Governor Kay Ivey called the project "the largest initial investment in our state's history."
Lilly said the plant will use machine learning, AI and digitally integrated monitoring systems, with automation embedded across operations.
The company also aims to work toward carbon neutrality at the site, said Edgardo Hernandez, Lilly's manufacturing operations head.
(Reporting by Puyaan Singh in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Huge solar flare no threat to Artemis 2 astronaut launch to the moon, NASA says - 2Study reveals links between global food systems, obesity, and climate change
- 3Thousands of New York City nurses set to strike Monday if deal isn't reached with hospitals
- 4Study finds humans were making fire 400,000 years ago, far earlier than once thought
- 5Ski Resorts Universally: A Colder time of year Wonderland Guide
- A definitive Manual for Choosing Indoor Plants Ideal for Your Space
- What happened to Eleven after the ambiguous 'Stranger Things' series finale? Millie Bobby Brown knows — but 'swore herself to secrecy'
- Share your pick for the riding area that characterizes your surf undertakings!
- Figure out How to Pick the Right Dental specialist for Your Dental Inserts
- SpaceX rocket launches 140 satellites into orbit on Transporter-15, aces landing at sea (video)
- Luigi Mangione‘s lawyers say Bondi’s death penalty decision was tainted by conflict of interest
- NASA to bring astronauts home from space station early due to a medical issue
- The Way to Business: Startup Illustrations Learned
- CDC vaccine panel votes to remove universal hepatitis B birth dose recommendation
